Trailing-twelve-month (TTM) revenue is $249.25 Million with a year-over-year growth of +2.47%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $61,547,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $62,605,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-03 |
| Q1 FY2026Period ended 2026-03-31 | $62,143,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $62,958,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $249,253,000 |
Current P/S: $275,201,929 market capitalization ÷ $249,253,000 TTM revenue = 1.10x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:05:12.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $62.96M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:05:44.893Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Grant | $388,000 | $570,000 | $624,000 | N/A | N/A | N/A |
| Product | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $103M | N/A | $140M | $126M | $125M | $128M |
| Americas, principally the U.S. | N/A | $116M | N/A |
$249.25M
$249.25 Million
+2.47%
vs. $243.24M a year ago (TTM)
+1.22%
5 Year compound annual growth rate
1 Year
+2.47%
3 Year
(1.35%)
5 Year
+1.22%
10 Year
+5.90%
15 Year
+2.94%
20 Year
+3.51%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $245.60M | +$3.43M | +1.42% |
| 2024 | $242.18M | ($2.21M) | (0.90%) |
| 2023 | $244.38M | ($30.71M) | (11.16%) |
| 2022 | $275.09M | +$26.17M | +10.51% |
| 2021 | $248.92M | +$28.15M | +12.75% |
| 2020 |
TTM Growth
+2.47%
3-Year CAGR
(1.35%)
5-Year CAGR
+1.22%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:05:44.893Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $115M |
| Products | N/A | N/A | N/A | $124M | $112M | N/A |
|---|
| Service | N/A | N/A | N/A | $120M | $130M | $131M |
|---|
| N/A |
| N/A |
| N/A |
| Eastern Asia | N/A | N/A | $42M | $35M | $33M | N/A |
|---|
| Europe | $75M | $89M | $88M | $79M | $77M | $78M |
|---|
| Far East | $36M | $39M | N/A | N/A | N/A | N/A |
|---|
| Israel | N/A | $5M | $6M | $4M | $8M | N/A |
|---|
| ISRAEL | N/A | N/A | N/A | N/A | N/A | $6M |
|---|
| $220.77M |
| +$20.49M |
| +10.23% |
| 2019 | $200.29M | +$24.06M | +13.66% |
| 2018 | $176.22M | +$19.48M | +12.43% |
| 2017 | $156.74M | +$11.17M | +7.67% |
| 2016 | $145.57M | +$5.81M | +4.16% |
